View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Nivolumab - Relatlimab 640, Malignant Melanoma
Protocol-ID: 2329 V1.0 (Mini), NIVO-RELA640, Malignant MelanomaIndication(s)
- Melanoma, Malignant; ICD-10 C44.-
Links
- Nivolumab und Relatlimab [EMA EPAR]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 30.06.2023